EC Healthcare (HKG:2138)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.4200
-0.0050 (-1.18%)
Aug 12, 2026, 3:52 PM HKT

EC Healthcare Cash Flow Statement

Millions HKD. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
-402.72-167.19-18.9569.65197.5
Depreciation & Amortization
510.43629.19623.74584.85430.36
Other Amortization
1.821.781.811.892
Loss (Gain) From Sale of Assets
-22.49-266.921.84-3.64-19.12
Asset Writedown & Restructuring Costs
409.77184.2926.385.28-10.8
Loss (Gain) From Sale of Investments
4.1326.7524.5819.0911.57
Loss (Gain) on Equity Investments
-8.595.43-5.43-12.330.67
Stock-Based Compensation
15.1420.2711.9563.1227.69
Other Operating Activities
28.87100.2172.0345.96103.26
Change in Accounts Receivable
55.96-9.57-46.04-36.3251.23
Change in Inventory
-0.63-9.92-14.3119.97-45.19
Change in Accounts Payable
-20.39-11.34-11.53-14.24-0.34
Change in Unearned Revenue
-31.12-37.63-56.14-59.8291.14
Change in Other Net Operating Assets
66.31187.8779.17-78.19-231.61
Operating Cash Flow
606.56743.24689.1605.28608.36
Operating Cash Flow Growth
-18.39%7.86%13.85%-0.51%-2.00%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-58.69-57.17-161.22-411.01-260.27
Sale of Property, Plant & Equipment
4.723.2241.2912.3843.56
Cash Acquisitions
7.13-43.89-96.01-62.11-286.95
Divestitures
-3.85440.340.32--
Sale (Purchase) of Intangibles
----1.48-
Investment in Securities
-214.74-24-155.62-18.02-71.9
Other Investing Activities
-10.362.7912.89-243.534.37
Investing Cash Flow
-275.81341.28-358.36-723.77-571.19

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--10--
Long-Term Debt Issued
673.13112.5686.64494.33-
Total Debt Issued
673.13112.5696.64494.33-
Long-Term Debt Repaid
-1,131-534.43-823.13-357.12-555.04
Total Debt Repaid
-1,131-534.43-823.13-357.12-555.04
Net Debt Issued (Repaid)
-458.16-421.93-126.49137.22-555.04
Issuance of Common Stock
---8.51811.77
Common Dividends Paid
--11.85-55.69-118-271.96
Other Financing Activities
-112.32-200-304.29-67.84-84.73
Financing Cash Flow
-570.48-633.79-486.46-40.12-99.95

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Foreign Exchange Rate Adjustments
2.76-0.45-0.52-1.761.95
Net Cash Flow
-236.98450.29-156.23-160.37-60.84

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
547.87686.07527.88194.27348.09
Free Cash Flow Growth
-20.14%29.97%171.73%-44.19%-28.22%
Free Cash Flow Margin
14.53%16.57%12.54%5.01%11.92%
Free Cash Flow Per Share
0.460.580.450.160.30
Levered Free Cash Flow
403.02536.01225.53439.94449.14
Unlevered Free Cash Flow
447.81592.69288.55479.72479.71

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
65.5578.7791.6131.1524.2
Cash Income Tax Paid
39.872.6349.9685.5167.32
Change in Working Capital
70.13119.41-48.85-168.6-134.77